428PInterim results from a phase I trial of SL-801: A novel XPO-1 inhibitor, in patients with advanced solid tumors. (23rd October 2018) - Bauer, T M; Barve, M; Chiorean, E G; Lorusso, P; Courtney, K; Qi, D; Olguin, A; Bullington, J; Sardone, M; Dunn, V; Shemesh, S; Chen, J; et al.